Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Botulinum toxin in the management of children with cerebral palsy
During the past 25 years, botulinum toxin type A (BoNT-A) has become the most widely used
medical intervention in children with cerebral palsy. In this review we consider the gaps in …
medical intervention in children with cerebral palsy. In this review we consider the gaps in …
Muscle architecture, growth, and biological Remodelling in cerebral palsy: a narrative review
Cerebral palsy (CP) is caused by a static lesion to the brain occurring in utero or up to the
first 2 years of life; it often manifests as musculoskeletal impairments and movement …
first 2 years of life; it often manifests as musculoskeletal impairments and movement …
Skeletal muscle in cerebral palsy: from belly to myofibril
This review will provide a comprehensive, up-to-date review of the current knowledge
regarding the pathophysiology of muscle contractures in cerebral palsy. Although much has …
regarding the pathophysiology of muscle contractures in cerebral palsy. Although much has …
Progressive resistance training for children with cerebral palsy: A randomized controlled trial evaluating the effects on muscle strength and morphology
Children with spastic cerebral palsy often present with muscle weakness, resulting from
neural impairments and muscular alterations. While progressive resistance training (PRT) …
neural impairments and muscular alterations. While progressive resistance training (PRT) …
The contribution of decreased muscle size to muscle weakness in children with spastic cerebral palsy
Muscle weakness is a common clinical symptom in children with spastic cerebral palsy
(SCP). It is caused by impaired neural ability and altered intrinsic capacity of the muscles. To …
(SCP). It is caused by impaired neural ability and altered intrinsic capacity of the muscles. To …
[HTML][HTML] Over 25 years of pediatric botulinum toxin treatments: what have we learned from injection techniques, doses, dilutions, and recovery of repeated injections?
H Sätilä - Toxins, 2020 - mdpi.com
Botulinum toxin type A (BTXA) has been used for over 25 years in the management of
pediatric lower and upper limb hypertonia, with the first reports in 1993. The most common …
pediatric lower and upper limb hypertonia, with the first reports in 1993. The most common …
Sarcopenia, cerebral palsy, and botulinum toxin type A
» Children with cerebral palsy have muscles that are much smaller than muscles in typically
develo** peers.» Injections of botulinum toxin type A (BoNT-A) result in acute muscle …
develo** peers.» Injections of botulinum toxin type A (BoNT-A) result in acute muscle …
Reduced cross-sectional muscle growth six months after botulinum toxin type-A injection in children with spastic cerebral palsy
Botulinum Neurotoxin type-A (BoNT-A) injections are widely used as first-line spasticity
treatment in spastic cerebral palsy (SCP). Despite improved clinical outcomes, concerns …
treatment in spastic cerebral palsy (SCP). Despite improved clinical outcomes, concerns …
Measuring skeletal muscle morphology and architecture with imaging modalities in children with cerebral palsy: a sco** review
Aim To investigate the use of ultrasound and magnetic resonance imaging (MRI)
methodologies to assess muscle morphology and architecture in children with cerebral …
methodologies to assess muscle morphology and architecture in children with cerebral …
Stretching interventions in children with cerebral palsy: why are they ineffective in improving muscle function and how can we better their outcome?
Hyper-resistance at the joint is one of the most common symptoms in children with cerebral
palsy (CP). Alterations to the structure and mechanical properties of the musculoskeletal …
palsy (CP). Alterations to the structure and mechanical properties of the musculoskeletal …